United States: Patent Law and the Supreme Court: Patent Certiorari Petitions Pending

WilmerHale compiles lists of certiorari petitions that raise patent-law issues. This page contains a consolidated list of all recently pending petitions, organized in reverse chronological order by date of certiorari petition.

Recently pending, granted and denied certiorari petitions

Tde Petroleum Data Solutions, Inc. v. AKM Enterprise, Inc., No. 16-890

Question Presented:

Whether an issued patent for a software implemented industrial process that regulates and controls the operation of an oil rig, which is patentable subject matter under this Court's interpretation of 35 U.S.C. § 101 in Diamond v. Diehr, 450 U.S. 175 (1981), is rendered unpatentable subject matter after this Court's decision in Alice v. CLS Bank, 134 S.Ct. 2347 (2014)? 

Cert. petition filed 1/13/17.

CAFC Opinion, CAFC Argument

Nanovapor Fuels Group, Inc. v. Vapor Point, LLC, No. 16-892

Question Presented:

The US Constitution's Seventh Amendment guarantees the right to trial by jury if timely requested.

There is division and uncertainty among the circuit courts of appeals regarding the evidentiary-weight standard applicable to prove waiver of the right to a jury trial.

The proper evidentiary-weight standard should require explicit, clear, and unequivocal evidence of a waiver of this fundamental, constitutional right.

The Federal Circuit Court of Appeals erred by not applying the evidentiary-weight standard requiring waiver of a constitutional right to be explicit, clear, and unequivocal.

Thus, the question presented is:

Can a party forfeit a properly demanded trial by jury without an explicit, clear, and unequivocal waiver?

Cert. petition filed 1/11/17.

CAFC Opinion, CAFC Argument

DataTreasury Corp. v. Fidelity Nat. Information Services, No. 16-883

Question Presented:

Congress broadly provided in the Patent Act that "[w]hoever invents or discovers any new and useful process, machine, manufacture, or composition of matter, or any new and useful improvement thereof, may obtain a patent therefor . . . ." 35 U.S.C. § 101. This Court's 2014 decision in Alice v. CLS Bank requires courts, in their Section 101 analysis, to consider the effect of the patent in practice and if the patent merely claims well-understood, routine conventional activities previously known to the industry.

In that analysis, the Federal Circuit does not consider evidence of copying, unmet need, commercial success, and failure of others—often referred to as secondary considerations evidence in patent law. Ignoring that evidence has caused the Federal Circuit to hold ineligible groundbreaking, valuable inventions, such as the patents in this case. Should this Court grant certiorari and hold that a court must consider secondary considerations evidence in its Section 101 analysis?

Cert. petition filed 1/11/17.

CAFC Opinion, CAFC Argument

Enplas Corp. v. Seoul Semiconductor Co., Ltd.,  No. 16-867

Questions Presented:

In 2011, Congress enacted the Leahy-Smith America Invents Act, Pub. L. No. 112-29, 125 Stat. 284 (2011) ("AIA") which established new post-grant adjudicatory processes for challenges to the validity of patents. One of those processes created by the Act is an inter partes review. The Act also created a body within the Patent and Trademark Office, called the Patent Trial and Appeal Board ("Board"), to hear those challenges as a quick and cost-effective alternative to litigation.  The decisions of the Board are subject to review by the Court of Appeals for the Federal Circuit and, as such, are subject to its precedents. 28 U.S.C. § 1295(a)(4)(A).

The Respondents Seoul Semiconductor Co. Ltd., et al. initiated an inter partes review (IPR2014-00605) of United States Patent No. 7,348,723 ("the ′'723 Patent"). At the conclusion of the IPR, the Board entered a Final Written Decision, finding the subject claims of the ′'723 Patent invalid as anticipated under 35 U.S.C. § 102 by U.S. Patent No. 5,577,493 ("Parkyn").

The law of anticipation clearly requires that each and every element be found, expressly or inherently, in the prior art. 35 U.S.C. § 102; see, e.g., Sanofi-Synthelabo v. Apotex, Inc., 550 F.3d 1075, 1082 (Fed. Cir. 2008); Summit 6, LLC v. Samsung Electronics Co., Ltd., 802 F.3d 1283, 1294 (Fed. Cir. 2015). Precedent requires the Board to make specific findings of fact in order to facilitate appellate review. Gechter v. Davidson, 116 F.3d 1454, 1460 (Fed. Cir. 1997) ("[W]e hold that the Board is required to set forth in its opinions specific findings of fact and conclusions of law adequate to form a basis for our review."). With respect to anticipation, such specific findings must include a limitation by limitation analysis. Id. ("In particular, we expect that the Board's anticipation analysis be conducted on a limitation by limitation basis, with specific fact findings for each contested limitation and satisfactory explanations for such findings.").

In this case, however, the Board failed to perform such a limitation by limitation analysis and, in turn, failed to make the requisite findings required to support a conclusion that the claims of the ′'723 Patent are invalid as anticipated under 35 U.S.C. § 102.  Petitioner appealed the Board's Final Written Decision to the Court of Appeals for the Federal Circuit on grounds including, inter alia, the Board's failure to make the requisite findings of fact and, further, that the Board could not have made the requisite findings because the relied upon prior art fails to disclose each and every element of the claims of the ′'723 Patent.  In particular, Parkyn fails to disclose the claim element requiring two recited conditions for light emitted within the entire "half-intensity-angular-range."

It is undisputed that the Board's Final Written Decision fails to make any finding concerning the "half-intensity-angular-range." Thus, the Board's Final Written Decision is prima facie defective under the controlling law. At the oral argument on appeal, Respondents' counsel conceded that Parkyn does not even discuss the "half-intensity-angular-range." Thus, the Board's Final  Written Decision is per se in conflict with controlling law. The Appellate Court's failure to follow its own precedents creates a conflict of law necessitating this Court's resolution.

Accordingly, Petitioner Enplas presents the following questions:

  1. Whether the Board is required to make specific findings of fact in support of its Final Written Decision?
  2. Whether a finding of anticipation under 35 U.S.C. § 102 must be supported by findings that each and every element of the subject patent claim is disclosed in the prior art?
  3. Whether the Board erred in finding the subject claims anticipated under 35 U.S.C. § § 102 by a reference that admittedly fails to disclose each and every element of said claims?
  4. Whether the Federal Circuit committed a legal and/or procedural error by affirming the decision of the Board finding the ′'723 Patent invalid as anticipated under 35 U.S.C. § § 102, when (a) the Board's opinion failed to set forth evidence to satisfy the requirement that all elements were in fact present in the prior art, and (b) substantial evidence demonstrated those omitted claim elements were not present in the prior art?

Cert. petition filed 1/9/17.

CAFC Opinion, CAFC Argument

IPLearn-Focus, LLC v. Microsoft Corp., No. 16-859

Questions Presented:

  1. Can patent claims be invalidated under 35 U.S.C. § 101 by finding under Alice step two that they involve the conventional implementation of an abstract concept, where the only evidence of record is that the ordered combinations of hardware in the claims are unconventional apparatuses with novel applications?
  2. Can claims be invalidated under 35 U.S.C. § 101 by declaring them to be directed to an abstract idea based on statements of purpose in the patent specification without considering whether the claims are directed to improvements to computer functionality rather than to economic or other tasks for which a computer is used in its ordinary capacity?

Cert. petition filed 1/5/17, waiver of respondent Microsoft Corp. filed 1/9/17, conference 2/17/17.

CAFC Opinion, CAFC Argument

Oil States Energy Services, LLC v. Greene's Energy Group, LLC, No. 16-712

Questions Presented:

  1. Whether inter partes review—an adversarial process used by the Patent and Trademark Office (PTO) to analyze the validity of existing patents—violates the Constitution by extinguishing private property rights through a non-Article III forum without a jury.
  2. Whether the amendment process implemented by the PTO in inter partes review conflicts with this Court's decision in Cuozzo Speed Technologies, LLC v. Lee, 136 S. Ct. 2131 (2016), and congressional direction.
  3. Whether the "broadest reasonable interpretation" of patent claims—upheld in Cuozzo for use in inter partes review—requires the application of traditional claim construction principles, including disclaimer by disparagement of prior art and reading claims in light of the patent's specification.

Cert. petition filed 11/23/16, waiver of respondent Michelle Lee, Director, Patent and Trademark Office filed 12/12/16.

CAFC Opinion, CAFC Argument

Google Inc. v. Arendi S.A.R.L., No. 16-626

Question Presented:

In KSR International Co. v. Teleflex, Inc., this Court rejected the Federal Circuit's "rigid" approach to analyzing the obviousness of patent claims in favor of the "expansive and flexible" approach of the Court's own cases. 550 U.S. 398, 415 (2007). The Court stressed that "[r]igid preventative rules that deny factfinders recourse to common sense . . . are neither necessary under our case law nor consistent with it." Id. at 421.

In this case, the Patent Trial and Appeal Board relied on the common sense of a skilled artisan in determining that it was obvious to search a database for duplicate entries before adding new information to the database. In making that finding, the Board cited expert testimony on both sides, including respondent Arendi's expert's concession that checking for duplicates before adding items to databases was commonplace. The Federal Circuit reversed, however, limiting KSR to cases involving the motivation to combine two prior-art references and holding that common sense could not supply a non-"peripheral" "missing limitation."

Did the Federal Circuit err in restricting the Board's ability to rely on the common sense and common knowledge of skilled artisans to establish the obviousness of patent claims?

Cert. petition filed 11/8/16, waiver of respondent Arendi S A.R.L. filed 11/21/16, waiver of respondent Apple, Inc. file 12/8/16, response requested 12/12/16.

CAFC Opinion, CAFC Argument

Big Baboon, Inc. v. Lee, No. 16-496

Question Presented:

In Christianson v. Colt Industries, 486 U.S. 800 (1988), this Court held that the Court of Appeals for the Federal Circuit does not have appellate jurisdiction under 28 U.S.C. § 1295(a)(1) when the claims of a well-pleaded complaint do not "arise under federal patent law." The Petitioner filed an action in district court under the Administrative Procedure Act (APA) seeking to have specific evidentiary admission decisions by the Director of the United States Patent and Trademark Office (USPTO) during patent reexaminations overturned as violating due process, and the complaint was dismissed. The Court of Appeals for the Ninth Circuit transferred the appeal of the dismissal to the Federal Circuit over the objection of the Petitioner, even though all parties agreed that Ninth Circuit law governed the only claim of the complaint.  Can the Federal Circuit impute a patent law claim into a complaint that does not explicitly contain a claim arising under patent law in order to exert appellate jurisdiction?

Cert. petition filed 10/10/16, waiver of respondent Michelle K. Lee, Director, United States Patent and Trademark Office et al. filed 10/19/16, response requested 10/28/16, conference 2/17/17.

CAFC Opinion, CAFC Argument

Boston Scientific Corp. v. Mirowski Family Ventures, LLC, No. 16-470

Question Presented:

Whether the court below, in deciding federal patent questions that are necessarily implicated by state law claims, contravened this Court's direction in Gunn v. Minton, 133 S. Ct. 1059 (2013), to "hew closely to the pertinent federal precedents," by (1) failing to perform necessary patent claim construction, (2) disregarding the settled meaning of the term "covered by" in patent jurisprudence, and (3) ignoring the fundamental distinction between method and apparatus claims, as established by the Federal Circuit.

Cert. petition filed 10/7/16, waiver of respondent Mirowski Family Ventures, LLC filed 10/17/16, response requested 11/10/16.

Maryland Ct. of Special Appeals Opinion, No Maryland Ct. of Special Appeals Argument Available

Romag Fasteners, Inc. v. Fossil, Inc., No. 16-202

Questions Presented:

Section 43(a) of the Lanham Act prohibits trademark infringement through false representations regarding the origin, endorsement, or association of goods through the use of another's distinctive mark. 15 U.S.C. § 1125(a). Section 35 of the Lanham Act permits a trademark holder who establishes a violation of Section 43(a) to recover the infringer's profits, among other damages. Id. § 1117(a). The federal circuits are intractably divided—six to six—over whether a trademark holder also must establish that the infringement was willful in order recover an award of profits.

The questions presented are:

  1. Whether, under Section 35 of the Lanham Act, willful infringement is a prerequisite for an award of infringer's profits for a violation of section 43(a).
  2. Whether and to what extent the defense of laches may bar an award for patent infringement brought within the Patent Act's six-year statutory limitations period, 35 U.S.C. § 286—the same issue this Court granted for plenary review in SCA Hygiene Products Aktiebolag v. First Quality Baby Products, LLC, No. 15-927.

Cert. petition filed 8/12/16, conference 11/22/16.

CAFC Opinion, CAFC Argument

Endotach LLC v. Cook Medical LLC, No. 16-127

Questions Presented:

Petitioner respectfully requests that this case be held in view of SCA Hygiene Prods. Aktiebolag v. First Quality Baby Prods., LLC, 136 S. Ct. 1824 (2016) ("SCA II"), No. 15-927. In SCA II, this Court granted a petition for writ of certiorari in order to determine if the defense of laches could bar a claim for patent infringement brought within the six-year statutory limitations period of the Patent Act. The granting of the writ followed this Court's decision in Petrella v. Metro-Goldwyn-Mayer, 134 S. Ct. 1962 (2014), which held the defense of laches cannot be used to shorten the three-year copyright limitations period set forth in 17 U.S.C. § 507(b). In Petrella, this Court noted that "we have never applied laches to bar in their entirety claims for discrete wrongs occurring within a federally prescribed limitations period." 134 S. Ct. at 1975.

The Federal Circuit ignored this Court's Petrella guidance shortly thereafter in a divisive 6-5 split en banc opinion in SCA Hygiene Prods. Aktiebolag v. First Quality Baby Prods., LLC, 807 F.3d 1311, 1333 (Fed. Cir. 2015) ("SCA I"), and instead carved out a patent-specific approach for laches. The dissent in SCA I recognized the conflict with Petrella, noting "[t]he Supreme Court has repeatedly cautioned this court not to create special rules for patent cases. In light of the Supreme Court's clear, consistent, and longstanding position on the unavailability of laches to bar damages claims filed within a statutory limitations period, we should not do so here." SCA I, at 1333. This Court has already recognized the benefit in reviewing the Federal Circuit's position on this matter and this petition presents the same vital question posed in SCA II:

Whether and to what extent the defense of laches may bar a claim for patent infringement brought within the Patent Act's six-year statutory limitations period, 35 U.S.C. § 286.

Cert. petition filed 7/25/16, waiver of respondent Cook Medical LLC filed 8/26/16, response requested 9/12/16, conference 1/6/17.

No CAFC Opinion—appeal terminated, CAFC Argument

Medinol Ltd. v. Cordis Corp., No. 15-998

Question Presented:

In Petrella v. Metro-Goldwyn-Mayer, this Court ruled that if a damages claim is timely under the relevant statute of limitations, judges cannot bar the claim by invoking the defense of laches. 134 S. Ct. 1962 (2014). The timeliness of the claim depends on "Congress' judgment," not the discretion of judges exercising their equitable powers. Id. at 1967.

In this case, the Federal Circuit affirmed the use of laches to dismiss damages claims that were timely under the Patent Act's statute of limitations. The Federal Circuit relied on a 6-5 en banc decision in SCA Hygiene Products Aktiebolag v. First Quality Baby Prods., LLC, 807 F.3d 1311 (Fed. Cir. 2015), that disregarded Petrella's admonition that "courts are not at liberty to jettison Congress' judgment on the timeliness of suit." 134 S. Ct. at 1967. Rather than following Petrella, the Federal Circuit created an exception for damages claims in patent cases.

The question presented is:

May judges use the equitable defense of laches to bar legal claims for damages that are timely under the express terms of the Patent Act.

Cert. petition filed 2/2/16, conference 4/22/16, conference 4/29/16.

CAFC Opinion was unpublished, No CAFC Argument

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.